 Shaodong Dai
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell | 9 | 2022 | 615 | 2.340 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2022 | 959 | 1.920 |
Why?
| | Nickel | 4 | 2021 | 50 | 1.860 |
Why?
| | Hypersensitivity | 7 | 2021 | 252 | 1.690 |
Why?
| | Autoantigens | 7 | 2022 | 396 | 1.240 |
Why?
| | Peptides | 11 | 2022 | 848 | 1.230 |
Why?
| | Prosthesis Failure | 2 | 2021 | 115 | 1.220 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 309 | 1.150 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2022 | 352 | 1.100 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2022 | 3244 | 1.050 |
Why?
| | Berylliosis | 5 | 2016 | 177 | 0.970 |
Why?
| | Models, Molecular | 23 | 2021 | 1369 | 0.940 |
Why?
| | Haptens | 2 | 2021 | 21 | 0.860 |
Why?
| | T-Lymphocytes | 7 | 2021 | 1736 | 0.850 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 687 | 0.830 |
Why?
| | Insulin | 4 | 2022 | 2076 | 0.820 |
Why?
| | Peptide Fragments | 4 | 2020 | 665 | 0.780 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 160 | 0.740 |
Why?
| | Joint Prosthesis | 1 | 2021 | 24 | 0.730 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 555 | 0.720 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 174 | 0.710 |
Why?
| | Epitopes | 3 | 2017 | 435 | 0.710 |
Why?
| | Bryostatins | 1 | 2020 | 1 | 0.700 |
Why?
| | Protein Conformation | 13 | 2021 | 805 | 0.630 |
Why?
| | Machine Learning | 1 | 2022 | 316 | 0.620 |
Why?
| | Arthroplasty, Replacement | 2 | 2020 | 44 | 0.600 |
Why?
| | Protein Processing, Post-Translational | 4 | 2018 | 399 | 0.590 |
Why?
| | Echinococcus granulosus | 1 | 2017 | 1 | 0.580 |
Why?
| | Organogold Compounds | 1 | 2017 | 5 | 0.580 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 18 | 0.580 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 64 | 0.570 |
Why?
| | Transcriptome | 2 | 2020 | 725 | 0.540 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2021 | 170 | 0.520 |
Why?
| | Amino Acid Sequence | 10 | 2019 | 1982 | 0.460 |
Why?
| | Protein Binding | 13 | 2020 | 1889 | 0.450 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 219 | 0.450 |
Why?
| | HLA-DP beta-Chains | 5 | 2016 | 76 | 0.450 |
Why?
| | Animals | 28 | 2024 | 31694 | 0.440 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 32 | 0.430 |
Why?
| | Mice | 20 | 2022 | 14860 | 0.420 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1477 | 0.410 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 13 | 0.410 |
Why?
| | Beryllium | 4 | 2016 | 146 | 0.410 |
Why?
| | Metals | 1 | 2013 | 106 | 0.400 |
Why?
| | Arthropod Proteins | 1 | 2012 | 4 | 0.400 |
Why?
| | Salivary Proteins and Peptides | 1 | 2012 | 10 | 0.400 |
Why?
| | Aprotinin | 1 | 2012 | 9 | 0.400 |
Why?
| | Ticks | 1 | 2012 | 12 | 0.400 |
Why?
| | Crystallography, X-Ray | 11 | 2018 | 402 | 0.400 |
Why?
| | Ixodes | 1 | 2012 | 10 | 0.400 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 63 | 0.390 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2022 | 21 | 0.390 |
Why?
| | Evolution, Molecular | 2 | 2012 | 430 | 0.360 |
Why?
| | Alleles | 3 | 2010 | 789 | 0.340 |
Why?
| | Binding Sites | 6 | 2017 | 1168 | 0.330 |
Why?
| | Ferredoxins | 1 | 2007 | 3 | 0.290 |
Why?
| | Protein Structure, Tertiary | 8 | 2012 | 796 | 0.290 |
Why?
| | Iron-Sulfur Proteins | 1 | 2007 | 24 | 0.290 |
Why?
| | Humans | 29 | 2023 | 114623 | 0.280 |
Why?
| | Oxidoreductases | 1 | 2007 | 92 | 0.280 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2785 | 0.270 |
Why?
| | HIV Infections | 1 | 2020 | 2469 | 0.260 |
Why?
| | Antigens | 2 | 2020 | 318 | 0.240 |
Why?
| | Hybridomas | 3 | 2021 | 230 | 0.240 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1314 | 0.230 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 59 | 0.230 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 143 | 0.220 |
Why?
| | Molecular Conformation | 2 | 2022 | 135 | 0.220 |
Why?
| | Amino Acids | 2 | 2022 | 448 | 0.220 |
Why?
| | HLA-DR Serological Subtypes | 2 | 2013 | 4 | 0.210 |
Why?
| | Polychlorinated Biphenyls | 1 | 2002 | 7 | 0.210 |
Why?
| | Oxygenases | 1 | 2002 | 9 | 0.210 |
Why?
| | Nucleic Acids | 1 | 2024 | 59 | 0.210 |
Why?
| | Disulfides | 2 | 2022 | 90 | 0.210 |
Why?
| | Receptors, Steroid | 1 | 2023 | 47 | 0.210 |
Why?
| | Dioxygenases | 1 | 2002 | 25 | 0.210 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 31 | 0.210 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 8 | 0.210 |
Why?
| | Histones | 3 | 2018 | 535 | 0.200 |
Why?
| | Bacterial Proteins | 4 | 2018 | 736 | 0.200 |
Why?
| | Hepatitis B virus | 1 | 2022 | 25 | 0.200 |
Why?
| | AlkB Enzymes | 1 | 2022 | 1 | 0.200 |
Why?
| | Germ Cells | 1 | 2022 | 57 | 0.200 |
Why?
| | Hirudo medicinalis | 1 | 2022 | 3 | 0.200 |
Why?
| | Leeches | 1 | 2022 | 3 | 0.200 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 47 | 0.200 |
Why?
| | Rift Valley fever virus | 1 | 2021 | 2 | 0.200 |
Why?
| | Support Vector Machine | 1 | 2022 | 34 | 0.200 |
Why?
| | Transglutaminases | 1 | 2022 | 142 | 0.190 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 5 | 0.190 |
Why?
| | Protein Structure, Secondary | 3 | 2012 | 325 | 0.190 |
Why?
| | VDJ Exons | 1 | 2021 | 1 | 0.190 |
Why?
| | Glycoproteins | 2 | 2014 | 304 | 0.190 |
Why?
| | Environmental Pollutants | 1 | 2002 | 110 | 0.180 |
Why?
| | Early Growth Response Protein 2 | 1 | 2020 | 10 | 0.180 |
Why?
| | Mutation | 5 | 2020 | 3344 | 0.180 |
Why?
| | Sequence Alignment | 3 | 2012 | 323 | 0.180 |
Why?
| | GATA2 Transcription Factor | 1 | 2020 | 12 | 0.180 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 31 | 0.180 |
Why?
| | STAT5 Transcription Factor | 1 | 2020 | 44 | 0.180 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.180 |
Why?
| | Muromegalovirus | 1 | 2020 | 13 | 0.180 |
Why?
| | Transcription Factor AP-1 | 1 | 2020 | 80 | 0.180 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 151 | 0.180 |
Why?
| | Response Elements | 1 | 2020 | 82 | 0.180 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 78 | 0.180 |
Why?
| | Toxoplasma | 1 | 2020 | 31 | 0.170 |
Why?
| | Toxoplasmosis | 1 | 2020 | 31 | 0.170 |
Why?
| | Interleukin-13 | 1 | 2020 | 122 | 0.170 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 197 | 0.170 |
Why?
| | Mast Cells | 1 | 2020 | 116 | 0.170 |
Why?
| | Trace Elements | 1 | 2020 | 45 | 0.170 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 221 | 0.170 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 84 | 0.170 |
Why?
| | Sarcoidosis | 1 | 2021 | 135 | 0.170 |
Why?
| | Major Histocompatibility Complex | 3 | 2013 | 217 | 0.170 |
Why?
| | Virus Latency | 1 | 2020 | 80 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 188 | 0.160 |
Why?
| | Herpesviridae Infections | 1 | 2020 | 138 | 0.160 |
Why?
| | Purines | 1 | 2020 | 159 | 0.160 |
Why?
| | Chronic Disease | 3 | 2020 | 1578 | 0.160 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 101 | 0.160 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 21 | 0.160 |
Why?
| | Antigen Presentation | 3 | 2020 | 188 | 0.160 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2018 | 51 | 0.160 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.160 |
Why?
| | Enzyme Inhibitors | 2 | 2017 | 750 | 0.150 |
Why?
| | Protein Kinase C | 1 | 2020 | 273 | 0.150 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 723 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 551 | 0.150 |
Why?
| | Thymus Gland | 1 | 2019 | 296 | 0.150 |
Why?
| | Histone Demethylases | 1 | 2018 | 28 | 0.150 |
Why?
| | Protein Domains | 1 | 2019 | 207 | 0.150 |
Why?
| | Autoimmunity | 2 | 2014 | 813 | 0.150 |
Why?
| | Helminth Proteins | 1 | 2017 | 19 | 0.140 |
Why?
| | Glutaredoxins | 1 | 2017 | 11 | 0.140 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 58 | 0.140 |
Why?
| | Insecta | 1 | 2017 | 64 | 0.140 |
Why?
| | Immune Tolerance | 1 | 2019 | 323 | 0.140 |
Why?
| | Pyrimidines | 1 | 2020 | 376 | 0.140 |
Why?
| | Up-Regulation | 1 | 2020 | 807 | 0.140 |
Why?
| | Pancreas | 1 | 2019 | 276 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2022 | 645 | 0.140 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1037 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1551 | 0.140 |
Why?
| | Cysteine | 1 | 2017 | 171 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 445 | 0.130 |
Why?
| | Protein Folding | 1 | 2017 | 239 | 0.130 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 2710 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2084 | 0.130 |
Why?
| | Catalytic Domain | 3 | 2021 | 196 | 0.130 |
Why?
| | Chromogranin A | 1 | 2015 | 39 | 0.120 |
Why?
| | Cancer Vaccines | 2 | 2021 | 137 | 0.120 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1313 | 0.120 |
Why?
| | Conserved Sequence | 2 | 2021 | 218 | 0.120 |
Why?
| | HIV-1 | 1 | 2020 | 768 | 0.120 |
Why?
| | DNA | 4 | 2024 | 1352 | 0.110 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2319 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1262 | 0.110 |
Why?
| | Phosphoproteins | 1 | 2014 | 298 | 0.100 |
Why?
| | Cross Reactions | 2 | 2011 | 117 | 0.100 |
Why?
| | Aged | 2 | 2022 | 19061 | 0.100 |
Why?
| | Blood | 1 | 2012 | 96 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1143 | 0.090 |
Why?
| | H-2 Antigens | 1 | 2011 | 110 | 0.090 |
Why?
| | Multigene Family | 1 | 2012 | 190 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2021 | 1947 | 0.090 |
Why?
| | Ligands | 4 | 2020 | 561 | 0.090 |
Why?
| | Lipids | 1 | 2014 | 580 | 0.090 |
Why?
| | RNA | 2 | 2022 | 809 | 0.090 |
Why?
| | Lysine | 1 | 2012 | 242 | 0.090 |
Why?
| | Oxidation-Reduction | 2 | 2018 | 923 | 0.090 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 61 | 0.090 |
Why?
| | Signal Transduction | 2 | 2020 | 4509 | 0.090 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 95 | 0.080 |
Why?
| | bcl-X Protein | 2 | 2006 | 38 | 0.080 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2021 | 129 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 2 | 2006 | 45 | 0.080 |
Why?
| | Membrane Proteins | 3 | 2006 | 1018 | 0.080 |
Why?
| | Allergens | 1 | 2013 | 413 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2023 | 695 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 720 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2010 | 211 | 0.080 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 115 | 0.070 |
Why?
| | Surface Plasmon Resonance | 1 | 2008 | 81 | 0.070 |
Why?
| | Spinacia oleracea | 1 | 2007 | 7 | 0.070 |
Why?
| | Synechocystis | 1 | 2007 | 4 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 10 | 0.070 |
Why?
| | Cohort Studies | 1 | 2017 | 4894 | 0.070 |
Why?
| | Thioredoxins | 1 | 2007 | 33 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 98 | 0.070 |
Why?
| | Electron Transport | 1 | 2007 | 108 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 81 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 208 | 0.070 |
Why?
| | Burkholderia | 1 | 2006 | 13 | 0.070 |
Why?
| | Female | 4 | 2021 | 59466 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2012 | 574 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 502 | 0.070 |
Why?
| | Hydrolases | 1 | 2006 | 51 | 0.070 |
Why?
| | Phenols | 1 | 2006 | 82 | 0.060 |
Why?
| | Iron | 1 | 2007 | 233 | 0.060 |
Why?
| | Complementarity Determining Regions | 3 | 2011 | 43 | 0.060 |
Why?
| | Demethylation | 1 | 2024 | 3 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2007 | 1230 | 0.060 |
Why?
| | Meiosis | 1 | 2024 | 59 | 0.060 |
Why?
| | Lung Diseases | 1 | 2010 | 701 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 80 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2003 | 140 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 200 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 213 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2002 | 36 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 616 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 244 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2021 | 80 | 0.050 |
Why?
| | Catalysis | 1 | 2002 | 289 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2021 | 24 | 0.050 |
Why?
| | Spodoptera | 1 | 2021 | 36 | 0.050 |
Why?
| | Interferon Type I | 1 | 2022 | 128 | 0.050 |
Why?
| | Middle Aged | 2 | 2021 | 26719 | 0.050 |
Why?
| | Interleukin-2 | 2 | 2015 | 413 | 0.050 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 79 | 0.050 |
Why?
| | Base Sequence | 2 | 2015 | 2114 | 0.050 |
Why?
| | Models, Chemical | 1 | 2002 | 248 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 337 | 0.050 |
Why?
| | Transcription Factors | 2 | 2006 | 1528 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 143 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2021 | 119 | 0.050 |
Why?
| | Caenorhabditis elegans | 1 | 2024 | 268 | 0.050 |
Why?
| | Antigens, Protozoan | 1 | 2020 | 19 | 0.040 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2020 | 41 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 27 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 136 | 0.040 |
Why?
| | Escherichia coli Proteins | 1 | 2022 | 162 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 184 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 52 | 0.040 |
Why?
| | Adult | 2 | 2021 | 30528 | 0.040 |
Why?
| | Protozoan Proteins | 1 | 2020 | 62 | 0.040 |
Why?
| | Antibody Affinity | 1 | 2020 | 52 | 0.040 |
Why?
| | Cell Line | 2 | 2020 | 2635 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2003 | 385 | 0.040 |
Why?
| | Genome | 1 | 2022 | 271 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2020 | 176 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 281 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2015 | 1083 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2018 | 4 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 3881 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 43 | 0.040 |
Why?
| | Salmonella | 1 | 2018 | 54 | 0.040 |
Why?
| | Genes, Bacterial | 1 | 2018 | 157 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1139 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 345 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 520 | 0.040 |
Why?
| | Apoptosis | 1 | 2006 | 2362 | 0.040 |
Why?
| | Protein Denaturation | 1 | 2017 | 68 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2018 | 174 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 142 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2021 | 770 | 0.040 |
Why?
| | Proline | 1 | 2017 | 72 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 635 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 288 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4689 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2018 | 785 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 238 | 0.030 |
Why?
| | Substrate Specificity | 2 | 2010 | 352 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 908 | 0.030 |
Why?
| | Male | 2 | 2021 | 55554 | 0.030 |
Why?
| | Baculoviridae | 1 | 2015 | 44 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2006 | 37 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2006 | 171 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3003 | 0.030 |
Why?
| | Sodium | 1 | 2014 | 183 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 510 | 0.030 |
Why?
| | Lung | 2 | 2016 | 3558 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1076 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2014 | 591 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 2 | 2006 | 608 | 0.020 |
Why?
| | HLA Antigens | 1 | 2013 | 224 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2011 | 51 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 44 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 32 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 72 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 193 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 124 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 111 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 620 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 130 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 372 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 6 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 356 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 669 | 0.020 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 13 | 0.020 |
Why?
| | Enterotoxins | 1 | 2006 | 88 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2010 | 476 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 151 | 0.020 |
Why?
| | Immunotherapy | 1 | 2010 | 474 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 84 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 104 | 0.020 |
Why?
| | Point Mutation | 1 | 2006 | 216 | 0.020 |
Why?
| | Transfection | 1 | 2006 | 866 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2186 | 0.010 |
Why?
| | B-Cell Activating Factor | 1 | 2003 | 18 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 65 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 223 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 176 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2003 | 311 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 353 | 0.010 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 285 | 0.010 |
Why?
| | Computer Simulation | 1 | 2003 | 872 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 591 | 0.010 |
Why?
|
|
Dai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|